Federal Funding Opportunities

Winship investigators have access to an extensive listing of cancer-related funding issued by the National Institutes of Health and other federal agencies. The listing updates automatically on a daily basis.

Use the column sorting, search filtering, and pagination tools to find and select federal funding opportunities below.

Cascade Link

Opportunity	Posted	Closing
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/11/22	01/07/25
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINIAMSNIDCR	01/11/22	01/07/25
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) Agency: NIH Institutions: NICHDNEINHLBINHGRINIANIAAANIDCDNIDANIMHNINDSNINRNIMHDNCI	01/10/22	01/07/25
Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity (R01 - Clinical Trials Optional) Agency: NIH Institutions: NIMHDNEINIANIAMSNIDCDNIDANINRNCIORWH	01/10/22	09/07/24
HEAL Initiative: National K12 Clinical Pain Career Development Program (K12 Clinical Trial Not Allowed) Agency: NIH Institutions: NINDSNIANICHDNIDCRNCCIHNCI	01/10/22	03/24/22
HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NINDSNIANIAAANIAMSNICHDNIDCRNIDDKNCCIHNCATSNCI	01/07/22	12/06/24
Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed) Agency: NIH Institutions: NCATSNIANIAAANIAMSNIDCRNIDANINDSNCCIHNCIORWH	01/06/22	05/01/23
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/03/22	09/22/22
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/03/22	09/22/22
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) Agency: NIH Institutions: NCI	01/03/22	09/22/22
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/03/22	09/22/22
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/03/22	09/22/22
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) Agency: NIH Institutions: NCI	01/03/22	09/22/22
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/03/22	09/22/22
U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trial Optional) Agency: NIH Institutions: NCIFIC	01/03/22	03/30/22
Technical Assistance Towards Strengthening Faith Based Organizations (FBOs) in Achieving Comprehensive HIV/AIDS/TB/STI Prevention, Care and Treatment Services in Zambia under the President's Emergency Plan for AIDS Relief (PEPFAR) Agency: CGH	12/30/21	02/28/22
Soroti Regional Mechanism for Reaching and Sustaining Epidemic Control in the Republic of Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR) Agency: CGH	12/30/21	02/28/22
Mubende Regional Mechanism for Reaching and Sustaining Epidemic Control in the Republic of Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR) Agency: CGH	12/30/21	02/28/22
Masaka Regional Mechanism for Reaching and Sustaining Epidemic Control in the Republic of Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR) Agency: CGH	12/30/21	02/28/22
Strengthening Sample Transportation System in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Agency: CGH	12/30/21	02/28/22
Kampala Regional Mechanism for Reaching and Sustaining Epidemic Control in the Republic of Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR) Agency: CGH	12/30/21	02/28/22
Health Promotion and Disease Prevention Research Centers: 2022 Special Interest Project Competitive Supplements (SIPS) Agency: HHSCDCERA	12/23/21	03/04/22
Transgender Status-Neutral Community-to-Clinic Models to End the HIV Epidemic Agency: NCHHSTP	12/22/21	02/25/22
Small Health Care Provider Quality Improvement Program Agency: HRSA	12/21/21	03/21/22
Enhanced Air Quality Monitoring for Communities Agency: EPA	12/13/21	02/25/22
Risk and Protective Factors of Family Health and Family Level Interventions (R01 - Clinical Trial Optional) Agency: NIH Institutions: NIMHDNINRNCIODPOBSSRSGMROORWH	12/13/21	05/07/25
High-Energy-Density Plasma Laboratory Science Agency: SC	12/08/21	02/07/22
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/23/21	09/22/22
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/23/21	09/22/22
Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/23/21	11/17/24
Biomanufacturing: Survival, Utility, and Reliability beyond Earth (BSURE) Agency: BTO	11/22/21	01/25/22
Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIMHDNIDCRNIEHSNIMHNCIODPOBSSRSGMRO	11/20/21	05/07/24
Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional) Agency: NIH Institutions: NICHDNEINHLBINHGRINIAAANIAIDNIAMSNIDCDNIDCRNIMHNINDSNCCIHNCIORWH	11/19/21	04/18/24
Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNCCIHNCATSORIP	11/19/21	02/02/24
Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional) Agency: NIH Institutions: NICHDNEINHLBINHGRINIAAANIAIDNIAMSNIDCDNIDCRNIMHNINDSNCCIHNCIORWH	11/19/21	12/13/23
Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed) Agency: NIH Institutions: NICHD	11/17/21	06/10/22
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required) Agency: NIH Institutions: NCI	11/05/21	02/28/22
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) Agency: NIH Institutions: NCI	11/03/21	02/28/22
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/03/21	02/28/22
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/03/21	09/22/22
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/03/21	09/22/22
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/03/21	01/07/25
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/03/21	01/07/25
Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed) Agency: NIH Institutions: NICHD	11/01/21	02/23/22
Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations Agency: NCCDPHP	10/28/21	01/26/22
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	10/21/21	09/13/24
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	10/12/21	10/08/24
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) Agency: NIH Institutions: NCI	10/12/21	01/07/25
Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trial Required) Agency: NIH Institutions: OPPNETNIANIAAANIDANINRNCCIHNCI	10/05/21	09/07/24
Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required) Agency: NIH Institutions: OPPNETNEINIANIAAANICHDNIDCRNIDANIMHNINDSNINRNIMHDNCIOBSSR	10/05/21	06/21/24
Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed) Agency: NIH Institutions: OPPNETNEINIANIAAANICHDNIDCRNIDANIMHNINDSNINRNIMHDNCCIHNCIOBSSR	10/05/21	06/21/24
Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional) Agency: NIH Institutions: FICNICHDNIDANIMHNCI	09/28/21	12/20/22
The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional) Agency: NIH Institutions: NCI	09/27/21	12/15/23
INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Exploratory/Developmental Research Grant Award (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: ODNEINHLBINIANIAIDNIAMSNICHDNIDCDNIDCRNCCIHORIPNCI	09/24/21	11/03/22
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	09/22/21	11/05/24
Development of Microbiome-Related Approaches for Diagnosis/Mitigation/Treatment of Radiation Injuries (U01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	09/20/21	02/09/22
Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	09/16/21	06/11/24
Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional) Agency: NIH Institutions: NCI	09/16/21	06/11/24
NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) Agency: NIH Institutions: NCI	09/10/21	09/07/24
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Independent Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	09/10/21	09/07/24
NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	09/10/21	09/07/24
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required) Agency: NIH Institutions: NCI	09/10/21	09/07/24
Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed) Agency: NIH Institutions: NCINICHDNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNIDCDNIDCRNIDANIDDKNIEHSNIGMSNIMHNINDSNINRNIMHDNCCIHNCATSNLMORIPNCIPCNCEHNIOSH	09/10/21	09/09/24
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	09/08/21	10/11/24
Emerging Global Leader Award (K43 Independent Clinical Trial Required) Agency: NIH Institutions: FICNCINHGRINIANIEHSNIMHNINDSORWH	09/08/21	12/11/23
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) Agency: NIH Institutions: FICNCINHGRINIANIDCRNIEHSNIMHNINDSORWH	09/08/21	12/11/23
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	09/03/21	09/07/24
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	09/03/21	09/07/24
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	09/02/21	09/07/24
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	09/02/21	09/07/24
Basic Research in Cancer Health Disparities (R03 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	09/02/21	09/07/24
National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	09/01/21	09/28/23
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	08/31/21	11/12/24
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required) Agency: NIH Institutions: NCI	08/31/21	11/12/24
Fiscal Year 2022 Consolidated Innovative Nuclear Research Agency: ID	08/30/21	02/23/22
Ecology and Evolution of Infectious Diseases Agency: NSF	08/27/21	11/16/22
Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	08/26/21	09/07/24
Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	08/26/21	09/07/24
Reproducible Cells and Organoids via Directed- Differentiation Encoding Agency: NSF	08/24/21	03/31/22
NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	08/20/21	10/06/23
Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDDKNICHDNCIODP	08/11/21	09/10/24
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) Agency: NIH Institutions: FICNEINIBIBNICHDNIDCDNIEHSNIMHNCIOBSSRORWH	08/04/21	12/09/22
2021 Human Exploration Research Opportunities (HERO) Agency: JSC	07/30/21	07/29/22
Research Centers for Cancer Systems Biology (U54 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	07/28/21	10/19/22
Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed) Agency: NIH Institutions: NIDA	07/22/21	02/17/22
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	07/22/21	09/07/24
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	07/22/21	09/07/24
Cancer Target Discovery and Development (CTD2) (U01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	07/12/21	10/06/22
Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed) Agency: NIH Institutions: NHGRINCINIAID	07/12/21	06/15/23
Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed) Agency: NIH Institutions: OPPNETNIANIAAANICHDNIDCRNIDANIMHNIMHDNCIOBSSRSGMROORWH	07/09/21	05/07/23
Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 - Basic Experimental Studies with Humans) Agency: NIH Institutions: OPPNETNIANIAAANICHDNIDCRNIDANIMHNIMHDNCIOBSSRSGMROORWH	07/09/21	05/07/23
PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) Agency: NIH Institutions: ODNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCATSORIPNCI	07/08/21	04/05/22
PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) Agency: NIH Institutions: ODNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCATSORIPNCI	07/08/21	04/05/22
PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) Agency: NIH Institutions: ODNEINHLBINHGRINIANIAAANIBIBNICHDNIDCDNIDANIEHSNIGMSNIMHNINRNIMHDNCCIHNCATSNCI	07/08/21	04/05/22
PHS 2021-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) Agency: NIH Institutions: ODNEINHLBINHGRINIANIAAANIBIBNICHDNIDCDNIDDKNIDANIEHSNIGMSNIMHNINRNIMHDNCCIHNCI	07/08/21	04/05/22
Exploiting in Vivo or in Situ Imaging Approaches to Understand HIV-relevant Processes In The Context of Substance Use Disorders (R61/R33 Clinical Trials Optional) Agency: NIH Institutions: NIDA	07/08/21	08/11/22
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional) Agency: NIH Institutions: FICNIAMSNIDDKNIDANIMHNCI	07/06/21	12/08/22
Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDDKNIAIDNIDCRNIEHSNCI	07/06/21	10/19/23
Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSNIBIBORIPODPOBSSRODSORWHOD	06/30/21	06/30/24
The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional) Agency: NIH Institutions: NIMHDNIANIDANIEHSNIMHNCISGMROORWH	06/25/21	09/07/24
Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 Clinical Trial Optional) Agency: NIH Institutions: NCI	06/03/21	12/01/24
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Required) Agency: NIH Institutions: NIDANEINHGRINIANIAAANICHDNIDCDNIMHNINDSNINRNCI	05/19/21	05/07/24
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) Agency: NIH Institutions: NIGMSNEINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIMHNINDSNINRNLMNCCIHNCI	05/19/21	05/07/24
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCINIDCR	03/25/21	01/07/24
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) Agency: NIH Institutions: NCI	03/25/21	01/07/24
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	03/18/21	11/17/23
Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) Agency: NIH Institutions: NIGMSNEINHGRINIANIAAANIAIDNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNINDSNINRNCI	03/18/21	01/07/24
Research on Bat Immunology (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	03/18/21	03/15/22
The NCI Transition Career Development Award (K22 Independent Basic Experimental Studies with Humans Required) Agency: NIH Institutions: NCI	03/15/21	03/14/24
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Required) Agency: NIH Institutions: NCI	03/15/21	03/14/24
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	03/15/21	03/14/24
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	03/12/21	03/07/24
HEAL Initiative: Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed) Agency: NIH Institutions: NINDSNEINIANIAAANIAMSNICHDNIDCRNIMHNCATSNCCIH	03/11/21	10/10/23
Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINHLBINIAAANIDANIEHSCTPODP	03/10/21	03/08/23
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) Agency: NIH Institutions: NIHNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNIMHDNLMNCCIHNCATSORIPNCI	02/10/21	01/07/24
Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed) Agency: NIH Institutions: ORIP	01/08/21	01/07/24
Cyber-Physical Systems Agency: NSF	01/08/21	06/15/22
International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed Agency: NIH Institutions: FICNCI	01/04/21	03/08/23
International Research Scientist Development Award (IRSDA) (K01 Independent Clinical Trial Required) Agency: NIH Institutions: FICNCI	01/04/21	03/08/23
Music and Health: Understanding And Developing Music Medicine (R01 Clinical Trial Optional) Agency: NIH Institutions: NINDSNEINIANIAAANIDCRNIDANIMHNINRNIMHDNCCIHNCIOBSSR	12/23/20	02/05/23
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional) Agency: NIH Institutions: NIANIAMSNIDCRNIDDKNIMHNINDSNCI	11/23/20	01/07/24
Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional) Agency: NIH Institutions: NIANIAMSNIDCRNIDDKNINDSNCI	11/23/20	01/07/24
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science Agency: NSF	11/20/20	11/10/22
Addressing Health Disparities among Immigrant Populations through Effective Interventions (R01 Clinical Trial Optional) Agency: NIH Institutions: NIMHDNIAAANIEHSNCIOBSSR	11/17/20	01/07/23
Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01 Clinical trial not allowed) Agency: NIH Institutions: NIMHDNIANIAAANIEHSNCI	11/17/20	01/07/23
Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/17/20	01/07/24
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPSGMRO	11/16/20	05/07/23
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) Agency: NIH Institutions: NCI	11/12/20	01/07/24
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) Agency: NIH Institutions: NCI	11/10/20	01/07/24
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINCCIHNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIMHNIMHDNINDSNINRNLMORIPORWH	11/09/20	12/28/23
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Humans Required) Agency: NIH Institutions: NCINCCIHNEINIANIAAANIAMSNICHDNIDCDNIDCRNIDANIEHSNIMHNIMHDNINDSNINRNLMORWH	11/09/20	12/28/23
Limited Competition: Lasker Clinical Research Scholars Transition Award (R00 Clinical Trial Optional) Agency: NIH Institutions: NCINHLBINIAAANIAIDNIDDK	11/05/20	09/30/23
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity) Agency: NIH Institutions: NCCIHNCINEINHGRINHLBINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDDKNIEHSNIMHNIMHDNINRNINDSNLMORIPNIDANIBIBNIGMS	10/28/20	09/07/23
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) Agency: NIH Institutions: NCCIHNCINEINHGRINHLBINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIEHSNIGMSNIMH	10/26/20	09/07/23
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) Agency: NIH Institutions: NCCIHNCINEINHLBINIANIAAANIAIDNICHDNIDCDNIDCRNIDDKNIEHSNIMHORIP	10/26/20	09/07/23
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) Agency: NIH Institutions: NCCIHNCINHLBINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIEHSNIGMSNIMHNINDSNLMORIP	10/26/20	12/08/23
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) Agency: NIH Institutions: NCCIHNCINEINHGRINHLBINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDDKNIEHSNIMHNIMHDNINRNINDSNLMORIP	10/21/20	09/07/23
University Nuclear Leadership Program– Scholarship and Fellowship Support Agency: ID	10/15/20	10/14/30
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPODPOBSSRODSORWH	10/13/20	10/07/23
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	10/13/20	10/10/23
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	10/13/20	10/10/23
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, and 2023 (P50 Clinical Trial Required) Agency: NIH Institutions: NCINIDCR	09/28/20	01/07/24
Department of Defense HIV/AIDS Prevention Program Agency: AMRAA	09/24/20	09/23/22
Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required) Agency: NIH Institutions: NCIODP	09/15/20	01/18/22
Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional) Agency: NIH Institutions: NCIODP	09/04/20	09/07/23
Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional) Agency: NIH Institutions: NCIODP	09/04/20	09/07/23
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/24/20	07/20/22
Research to Improve Native American Health (R21 Clinical Trials Optional) Agency: NIH Institutions: NIDANIAAANIAMSNIDCRNIEHSNIMHNINRNIMHDNLMNCCIHNCATSNCIOBSSR	08/17/20	09/07/23
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) Agency: NIH Institutions: NIDANHLBINIAAANIAIDNIAMSNIBIBNIDCRNIEHSNIMHNINRNIMHDNLMNCIOBSSR	08/17/20	09/07/23
Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	08/13/20	05/04/23
Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	08/05/20	11/09/22
Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) Agency: NIH Institutions: ODSNCINIDDKNIEHSNCCIH	07/30/20	04/15/22
Ethical, Legal and Social Implications (ELSI) (Research R01 Clinical Trial Optional) Agency: NIH Institutions: NHGRINCINEINHLBINIANIEHSNIMHNIMHDNINDSOBSSR	07/28/20	07/19/23
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21) (Clinical Trial Optional) Agency: NIH Institutions: NHGRINCINEINIANIEHSNIMHNINDSOBSSR	07/28/20	07/19/23
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03) Clinical Trial Optional) Agency: NIH Institutions: NHGRIFICNCINIANIEHSNIMHOBSSR	07/28/20	07/19/23
Fertility Status as a Marker for Overall Health (R01 Clinical Trial Optional) Agency: NIH Institutions: NICHDNIEHSNCIODPORWH	07/23/20	06/19/23
Fertility Status as a Marker for Overall Health (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NICHDNIEHSNCIODPORWH	07/23/20	06/19/23
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINHGRINIDCR	07/22/20	09/07/22
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) Agency: NIH Institutions: NCINHGRINIDCR	07/22/20	09/07/22
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINIDCDNIMH	07/20/20	01/07/23
Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional) Agency: NIH Institutions: NCCIHNIANIAAANIMHNCIOBSSR	07/15/20	06/19/23
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIBIBNIDCDNIDCRNIDDKNIEHSNIGMSNIMHNLMNCCIHNCATS	07/10/20	04/05/22
Administrative Supplement for Research on Dietary Supplements (Admin Supp-Clinical Trial Not Allowed) Agency: NIH Institutions: ODSNCINEINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIEHSNIMHDFICNCCIHORIP	06/09/20	04/15/23
Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 Basic Experimental Studies with Humans Required) Agency: NIH Institutions: OPPNETNIAAANIEHSNIMHNIMHDNCCIHNCIOBSSR	06/03/20	03/17/23
Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 No Independent Clinical Trials) Agency: NIH Institutions: OPPNETNIAAANIEHSNIMHNIMHDNCCIHNCIOBSSR	06/03/20	03/17/23
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) Agency: NIH Institutions: NCCIHODS	05/20/20	05/07/23
NCCIH Natural Product Mid Phase Clinical Trial Cooperative Agreement (U01 Clinical Trial Required) Agency: NIH Institutions: NCCIH	05/20/20	05/07/23
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required) Agency: NIH Institutions: NCCIHNCINHLBINHGRINIANIAAANIBIBNICHDNIDCDNIDCRNIDANIMHNINDSNIEHSNIMHD	05/12/20	05/07/23
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) Agency: NIH	05/12/20	05/07/23
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NIHNEINHGRINIANIAAANIAIDNIAMSNIDCDNIDCRNIDANIEHSNINRNIMHDNLMNCCIHNCIICs	05/07/20	05/07/23
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required) Agency: NIH Institutions: NCINHLBINHGRINIANIAAANIAMSNIBIBNICHDNIDANCCIHNIDDKNIEHSNIMHNINDSNINRNIMHD	05/05/20	05/07/23
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIHNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHORIPNCIICs	05/05/20	05/07/23
NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required) Agency: NIH Institutions: NCINEINIANIAAANICHDNIDCDNIDCRNIDANIEHSNIMHNIMHDNINDSNINRNCCIH	05/05/20	05/07/23
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIAIDNIBIBNCCIHNICHDNIDANIDCDNIDCRNIDDKNIEHSNIGMSNIMHNINDSNINRNLMORIPNIMHD	05/05/20	05/07/23
Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional) Agency: NIH Institutions: ODPNIANIDCDNIDANIMHNINRNIMHDNCCIHNCIOBSSR	04/30/20	09/07/23
Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional) Agency: NIH Institutions: ODPNIANIDCDNIDCRNCCIHNCI	04/30/20	09/07/23
Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) Agency: NIH Institutions: NIMHDNIANIDANCI	04/20/20	09/07/23
New Informatics Tools and Methods to Enhance U.S. Cancer Surveillance Research (U01 Clinical Trial Optional) Agency: NIH Institutions: NCI	04/15/20	06/06/23
Mechanisms and Consequences of Sleep Disparities in the U.S. (R01 - Clinical Trial Not Allowed) Agency: NIH Institutions: NIMHDNHLBINIANIAAANINDSNCI	04/03/20	07/14/22
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIBIBNIDCR	03/30/20	09/07/22
NIDA Small Research Grant Program (R03 Clinical Trial Required) Agency: NIH Institutions: NIDA	03/24/20	05/07/23
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) Agency: NIH Institutions: NCINEINHGRINHLBINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDDKNIDANIEHSNIGMSNIMHNINRNCCIHORIP	03/20/20	05/25/23
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	03/12/20	05/07/23
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) Agency: NIH Institutions: NCINCCIHNHGRINIAIDNICHDNIDDKNIEHSNIGMSNIMH	03/10/20	09/07/25
Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAIDNCINHLBINIANICHDNIDCRNIDDKNIDANIMHNINRNIMHDFIC	02/03/20	07/28/22
Centers for AIDS Research (P30 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAIDNCINHLBINIANICHDNIDCRNIDDKNIDANIMHNINRNIMHDFIC	02/03/20	07/28/22
National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/27/20	05/07/23
Genomic Expert Curation Panels (U24 Clinical Trial Not Allowed) Agency: NIH Institutions: NICHDNEINIMHNINDSNCI	01/23/20	05/26/22
Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed) Agency: NIH Institutions: NIGMSNIAAANIAIDNIDANIEHSNINDSNIMHDNCI	01/17/20	05/08/23
Biomedical Data Repository (U24 - Clinical Trials Not Allowed) Agency: NIH Institutions: NIGMSNIAAANIAIDNIDANIEHSNINDSNIMHDNCI	01/17/20	05/08/23
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01- Clinical Trial Not Allowed) Agency: NIH Institutions: NIMHDNCI	01/14/20	04/01/22
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21- Clinical Trial Not Allowed) Agency: NIH Institutions: NIMHDNCI	01/14/20	04/01/22
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	12/10/19	10/28/22
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	12/09/19	09/07/22
Co-infection and Cancer (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/22/19	01/07/23
Co-infection and Cancer (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/22/19	01/07/23
NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	11/22/19	01/07/23
Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/12/19	01/07/23
NCI Small Grants Program for Cancer Research for Years 2020, 2021, and 2022 (NCI Omnibus R03 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/08/19	01/07/23
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/04/19	10/12/21
Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	10/18/19	01/07/23
Integrative Research on Polysubstance Abuse and Disorder (R61/R33 Clinical Trial Optional) Agency: NIH Institutions: NIDANCI	10/18/19	11/07/22
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) Agency: NIH Institutions: NINDSNEINHLBINIANIAAANIAMSNIBIBNICHDNIDCRNIDDKNIGMSNIMHNINRNIMHDNLMNCCIHNCATSORIPNCI	10/04/19	09/08/22
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required) Agency: NIH Institutions: NINDSNEINHLBINIANIAAANIBIBNICHDNIDDKNIGMSNIMHNINRNIMHDNCCIHNCI	10/04/19	09/08/22
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required) Agency: NIH Institutions: NINDSNEINHLBINIANIAAANIBIBNICHDNIDDKNIGMSNIMHNINRNIMHDNCCIHNCI	10/04/19	09/08/22
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed) Agency: NIH Institutions: NINDSNEINHLBINIANIAAANIAMSNIBIBNICHDNIDCRNIDDKNIGMSNIMHNINRNIMHDNLMNCCIHNCATSORIPNCI	10/04/19	09/08/22
Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	10/02/19	01/07/23
Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIBIB	10/02/19	01/07/23
Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed) Agency: NIH Institutions: NICHDNHLBINIDCRNCI	09/12/19	01/07/23
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/29/19	07/16/22
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/29/19	09/07/22
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/29/19	09/07/22
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/29/19	09/07/22
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/29/19	09/07/22
Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	08/29/19	03/11/22
Neural Regulation of Cancer (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	08/28/19	05/27/22
Neural Regulation of Cancer (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	08/28/19	05/27/22
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/16/19	06/08/22
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/16/19	06/08/22
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/12/19	06/08/22
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/12/19	06/08/22
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	07/30/19	02/11/22
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	06/28/19	09/07/22
Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R33 Clinical Trial Optional) Agency: NIH Institutions: NIA	06/25/19	07/16/22
Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R21/R33 Clinical Trial Optional) Agency: NIH Institutions: NIA	06/25/19	07/16/22
Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional) Agency: NIH Institutions: NCI	05/22/19	01/28/22
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINHGRINIANIAAANICHDNIDCRNIDANIEHSNIMHNINDSFICODPOBSSRORWH	05/08/19	05/07/22
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINHLBINHGRINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDANIEHSNIMHNINDSNINRNIMHDNCCIHODPOBSSRORWH	05/08/19	05/07/22
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINHGRINIANIAAANIAIDNIAMSNIDCDNIDANIEHSNIMHNINDSNINRFICNCCIHODPOBSSRORWH	05/08/19	05/07/22
Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional) Agency: NIH Institutions: NCCIHNCINIANIAAANIDANIDCRNINDSNINROBSSRORWH	02/28/19	05/07/22
Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R01 Clinical Trial Optional) Agency: NIH Institutions: NCCIHNCINHLBINIANIAAANIDANIDCRNINDSNINROBSSRORWH	02/28/19	05/07/22
Microbial-based Cancer Therapy -Bugs as Drugs (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/22/19	05/07/22
Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/22/19	05/07/22
Biology of Bladder Cancer (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/05/19	05/07/22
Biology of Bladder Cancer (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/05/19	05/07/22
Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIBIBNIAAANIAMSNCINIDCRNIEHSNINDSNIANEI	01/08/19	05/07/22
Bioengineering Research Grants (BRG) (R01 Clinical Trial Required) Agency: NIH Institutions: NIBIBNCINIANIAAANINDSNEI	01/08/19	05/07/22
Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIANIAAANIDCRNIDANIMHNIMHD	09/21/18	05/07/22
Fundamental Research to Counter Weapons of Mass Destruction Agency: DTRA	03/20/15	09/30/24

TOP